- $360.48m
- $283.09m
- $35.08m
- 94
- 46
- 42
- 64
Annual income statement for Value Line, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 40.4 | 40.5 | 39.7 | 37.5 | 35.1 |
| Cost of Revenue | |||||
| Gross Profit | 35 | 35.5 | 34.5 | 32 | 29.1 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32.9 | 27.4 | 28.2 | 28.3 | 29.1 |
| Operating Profit | 7.54 | 13.1 | 11.5 | 9.14 | 5.99 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 30.3 | 30.6 | 23.8 | 25.2 | 27.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 23.3 | 23.8 | 18.1 | 19 | 20.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 23.3 | 23.8 | 18.1 | 19 | 20.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 23.3 | 23.8 | 18.1 | 19 | 20.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.43 | 2.31 | 1.91 | 2.02 | 2.2 |
| Dividends per Share |